课题基金 / 基金详情

项目摘要

项目成果

Patrick Duffy的其他基金

相似基金

相关文献

中文摘要
翻译
与NICHD发育和分子免疫学实验室的John Robbins和Rachel Schneerson博士合作,我们开发了一种由Pfs 25-Pfs 25缀合物组成的候选缀合物疫苗。偶联疫苗诱导的免疫血清显示出阻断疟原虫在蚊子体内发育的能力。向FDA提交了一份研究性新药申请,计划进行1期试验,以测试人体的安全性、免疫原性和离体传播阻断活性。 作为对FDA评论的回应,进行了额外的动物研究,以评价动物安全性。
英文摘要
In collaboration with Drs. John Robbins and Rachel Schneerson at the Laboratory of Developmental and Molecular Immunology of the NICHD, we have developed a candidate conjugate vaccine that consists of Pfs25-Pfs25 conjugates. The immune sera induced by the conjugate vaccine displayed ability to block parasite development in mosquitoes. An Investigational New Drug Application was filed with FDA, intending a Phase 1 trial to test the safety, immunogenicity, and ex-vivo transmission blocking activity in humans. In response to FDAs comment, additional animal studies were conducted to evaluate the safety in animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Malaria Surveillance and Research Studies in Liberia and Guinea-Conakry
Malaria Transmission Blocking Vaccine Discovery
Malaria Pathogenesis in young children and vaccine discovery
Gametocyte Carriage Rate and Transmission Blocking Vaccine Assay Development
国内基金
海外基金
Aluminum/CFRP 混合管界面分层对渐进折叠机制影响研究
  • 批准号:
    ZCLQN26E0501
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    沈勇
  • 依托单位: